Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.

N.E. Franke; D. Niewerth; Y.G. Assaraf; J. van Meerloo; K Vojtekova; C.H. van Zantwijk; S. Zweegman; E.T. Chan; D.P. Geerke; A.D. Schimmer; G.J.L. Kaspers; G. Jansen; J. Cloos

doi:10.1038/leu.2011.256

Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.

N.E. Franke, D. Niewerth, Y.G. Assaraf, J. van Meerloo, K Vojtekova, C.H. van Zantwijk, S. Zweegman, E.T. Chan, D.P. Geerke, A.D. Schimmer, G.J.L. Kaspers, G. Jansen, J. Cloos

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	757-768
Journal	Leukemia
Volume	26
Issue number	4
DOIs	https://doi.org/10.1038/leu.2011.256
Publication status	Published - 2012

Access to Document

10.1038/leu.2011.256

Cite this

Franke, N. E., Niewerth, D., Assaraf, Y. G., van Meerloo, J., Vojtekova, K., van Zantwijk, C. H., ... Cloos, J. (2012). Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. Leukemia, 26(4), 757-768. https://doi.org/10.1038/leu.2011.256

Franke, N.E. ; Niewerth, D. ; Assaraf, Y.G. ; van Meerloo, J. ; Vojtekova, K ; van Zantwijk, C.H. ; Zweegman, S. ; Chan, E.T. ; Geerke, D.P. ; Schimmer, A.D. ; Kaspers, G.J.L. ; Jansen, G. ; Cloos, J. / Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. In: Leukemia. 2012 ; Vol. 26, No. 4. pp. 757-768.

@article{9ff339ceac7b423fbe67a1a70a93f10c,

title = "Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.",

author = "N.E. Franke and D. Niewerth and Y.G. Assaraf and {van Meerloo}, J. and K Vojtekova and {van Zantwijk}, C.H. and S. Zweegman and E.T. Chan and D.P. Geerke and A.D. Schimmer and G.J.L. Kaspers and G. Jansen and J. Cloos",

year = "2012",

doi = "10.1038/leu.2011.256",

language = "English",

volume = "26",

pages = "757--768",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

Franke, NE, Niewerth, D, Assaraf, YG, van Meerloo, J, Vojtekova, K, van Zantwijk, CH, Zweegman, S, Chan, ET, Geerke, DP, Schimmer, AD, Kaspers, GJL , Jansen, G & Cloos, J 2012, 'Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.', Leukemia, vol. 26, no. 4, pp. 757-768. https://doi.org/10.1038/leu.2011.256

Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. / Franke, N.E.; Niewerth, D.; Assaraf, Y.G.; van Meerloo, J.; Vojtekova, K; van Zantwijk, C.H.; Zweegman, S.; Chan, E.T.; Geerke, D.P.; Schimmer, A.D.; Kaspers, G.J.L.; Jansen, G.; Cloos, J.

In: Leukemia, Vol. 26, No. 4, 2012, p. 757-768.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.

AU - Franke, N.E.

AU - Niewerth, D.

AU - Assaraf, Y.G.

AU - van Meerloo, J.

AU - Vojtekova, K

AU - van Zantwijk, C.H.

AU - Zweegman, S.

AU - Chan, E.T.

AU - Geerke, D.P.

AU - Schimmer, A.D.

AU - Kaspers, G.J.L.

AU - Jansen, G.

AU - Cloos, J.

PY - 2012

Y1 - 2012

U2 - 10.1038/leu.2011.256

DO - 10.1038/leu.2011.256

M3 - Article

C2 - 21941364

VL - 26

SP - 757

EP - 768

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -